CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed
Drug / intervention
Saccharomyces boulardiidrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00002088
NCT00002088Phase 2Completed
CompareCT.gov

Treatment of Patients With Human Immunodeficiency Virus (HIV)-Related Chronic Diarrhea With Saccharomyces Boulardii or Placebo: A Double Blind Trial

Biocodex·interventional·Posted Aug 31, 2001·Updated Jun 24, 2005

In Brief

A Phase 2 clinical trial evaluating Saccharomyces boulardii for Diarrhea and HIV Infections. Completed, across 1 site.

Detailed Summary

To assess the efficacy of Saccharomyces boulardii (a nonpathogenic yeast) in producing a significant reduction in diarrheal symptoms in HIV-infected patients with chronic diarrhea.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiarrhea, HIV Infections
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 31, 2001
TodayJul 2, 2026
Posted 24.8 years ago

Interventions

Saccharomyces boulardiidrug